“…The structure of benzo[b]thiophen-3-ol has been previously studied from a chemical point of view and several research groups have proposed synthetic strategies to obtain this class of compounds [23][24][25] . Here, we propose a new one-step, very simple synthetic procedure which allowed us to obtain the desired compounds PM1-PM20 (Scheme 1).…”
A series of benzo[
b
]thiophen-3-ols were synthesised and investigated as potential human monoamine oxidase (hMAO) inhibitors
in vitro
as well as
ex vivo
in rat cortex synaptosomes by means of evaluation of 3,4-dihydroxyphenylacetic acid/dopamine (DOPAC/DA) ratio and lactate dehydrogenase (LDH) activity. Most of these compounds possessed high selectivity for the MAO-B isoform and a discrete antioxidant and chelating potential. Molecular docking studies of all the compounds underscored potential binding site interactions suitable for MAO inhibition activity, and suggested structural requirements to further improve the activity of this scaffold by chemical modification of the aryl substituents. Starting from this heterocyclic nucleus, novel lead compounds for the treatment of neurodegenerative disease could be developed.
“…The structure of benzo[b]thiophen-3-ol has been previously studied from a chemical point of view and several research groups have proposed synthetic strategies to obtain this class of compounds [23][24][25] . Here, we propose a new one-step, very simple synthetic procedure which allowed us to obtain the desired compounds PM1-PM20 (Scheme 1).…”
A series of benzo[
b
]thiophen-3-ols were synthesised and investigated as potential human monoamine oxidase (hMAO) inhibitors
in vitro
as well as
ex vivo
in rat cortex synaptosomes by means of evaluation of 3,4-dihydroxyphenylacetic acid/dopamine (DOPAC/DA) ratio and lactate dehydrogenase (LDH) activity. Most of these compounds possessed high selectivity for the MAO-B isoform and a discrete antioxidant and chelating potential. Molecular docking studies of all the compounds underscored potential binding site interactions suitable for MAO inhibition activity, and suggested structural requirements to further improve the activity of this scaffold by chemical modification of the aryl substituents. Starting from this heterocyclic nucleus, novel lead compounds for the treatment of neurodegenerative disease could be developed.
A novel and efficient tandem S N 2 nucleophilic substitution/Dieckmann condensation reaction of α-iodomethyl phosphine oxide with methyl thiosalicylate derivatives has been developed by using NaOH as a base, which enables the expeditious synthesis of 2-phosphonyl-3-hydroxybenzo[b]thiophene derivatives in moderate to high yields under simple conditions. This research provides not only a convenient method for the functionalization of benzo[b]thiophenes at the 2-position and 3-position but also new organophosphorus molecules. Furthermore, several new phosphonyl-substituted benzo[b]thiophenes were obtained from the resultant 2-phosphonyl-3-hydroxybenzo[b]thiophenes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.